Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
To cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Jan 2026 and Apr 2026.
- Largest single sale: $873K (20,438 shares) of Scholar Rock Holding Corp on Jan 13, 2026. Filing
- Last sale before this period: May 29, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Hemab Therapeutics Holdings, Inc. (COAG) | Director | Apr 30, 2026 | Apr 30, 2026 |
| Scholar Rock Holding Corp (SRRK) | President of R&D, Director | May 23, 2019 | Apr 20, 2026 |
| Alnylam Pharmaceuticals, Inc. (ALNY) | Former President | Mar 13, 2009 | Aug 7, 2023 |
Also a director at
Recent filings
The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.